ERD

RETURNING INDIVIDUAL CLINICAL TRIAL DATA BACK TO PARTICIPANTS

Project: VISION DMD

Updated at: 29-04-2024

Show more information

Project acronym VISION DMD

Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflamma...

Project: VISION DMD

Updated at: 29-04-2024

Show more information

Project acronym VISION DMD

Vision DMD: Vamorolone (VBP15) drug development program for Duchenne muscular dystrophy

Project: VISION DMD

Updated at: 29-04-2024

Show more information

Project acronym VISION DMD

Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function

Project: VISION DMD

Updated at: 29-04-2024

Show more information

Project acronym VISION DMD

New therapies in neuromuscular disorders in childhood Nové možnosti léčby vrozených neuromuskulárních onemocněn�...

Project: VISION DMD

Updated at: 29-04-2024

Show more information

Project acronym VISION DMD

Future clinical trial design and innovative end points (Biomarkers and Imaging) for DMD and other Neuromuscular diseases...

Project: VISION DMD

Updated at: 29-04-2024

Show more information

Project acronym VISION DMD

VISION DMD Workshop Series

Project: VISION DMD

Updated at: 29-04-2024

Show more information

Project acronym VISION DMD

Pubertal induction in adolescents with DMD is associated with high satisfaction, gonadotropin release and increased musc...

Project: VISION DMD

Updated at: 29-04-2024

Show more information

Project acronym VISION DMD

Quantifying fat replacement of muscle by quantitative MRI in muscular dystrophy

Project: VISION DMD

Updated at: 29-04-2024

Show more information

Project acronym VISION DMD

Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clin...

Project: VISION DMD

Updated at: 29-04-2024

Show more information

Project acronym VISION DMD

Project Website

Project: VISION DMD

Updated at: 29-04-2024

Show more information

Project acronym VISION DMD

Periodic Reporting for period 4 - VISION DMD (VISION-DMD - Phase 2 Clinical Trials of VBP15: An Innovative Steroid-like ...

Project: VISION DMD

Updated at: 21-02-2023

Show more information

Project acronym VISION DMD

Resources

Selected filters:

RETURNING INDIVIDUAL CLINICAL TRIAL DATA BACK TO PARTICIPANTS

Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflamma...

Vision DMD: Vamorolone (VBP15) drug development program for Duchenne muscular dystrophy

Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function

New therapies in neuromuscular disorders in childhood Nové možnosti léčby vrozených neuromuskulárních onemocněn�...

Future clinical trial design and innovative end points (Biomarkers and Imaging) for DMD and other Neuromuscular diseases...

VISION DMD Workshop Series

Pubertal induction in adolescents with DMD is associated with high satisfaction, gonadotropin release and increased musc...

Quantifying fat replacement of muscle by quantitative MRI in muscular dystrophy

Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clin...

Project Website

Periodic Reporting for period 4 - VISION DMD (VISION-DMD - Phase 2 Clinical Trials of VBP15: An Innovative Steroid-like ...